Kroger Co vs Smith & Nephew plc — how do they compare? Kroger Co trades at $60.87 (market cap $36.27B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: Kroger Co is far larger — about 3.3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Kroger Co for 108 Days and Smith & Nephew plc for 121 Days on average.
| KR | SNN | |
|---|---|---|
Market Cap | $36.27B | $11.10B |
Volume | 8,301,523 | 1,051,703 |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $37.17 |
52-Week Low | $55.53 | $26.42 |
Typical Hold Time | 108 Days | 121 Days |
Enterprise Value | $57.69B | $14.13B |
Dividend Yield | 2.54% | 2.95% |
Signals from Pluang's Aura AI — not financial advice
Kroger (KR) trades at $61.64, up 4.03% today, with a bullish technical signal supported by moving averages. The stock shows mixed fundamentals with a low P/S ratio of 0.26 but elevated P/E of 33.19, while recent earnings beat expectations in two of the last three quarters. Analyst consensus is moderately bullish with a $70.62 price target, representing 14.6% upside potential from current levels.
Kroger offers value through its low valuation multiples and consistent dividends, but faces headwinds from competitive pressures and integration risks from pending acquisitions. The company's digital growth initiatives and retail media expansion provide growth catalysts, though margin compression remains a concern amid rising costs and softer sales guidance for fiscal 2026.
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →